H. Sleeboom

发表

Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.

A. V. van Oosterom, J. Elte, O. Bijvoet, 1986, European journal of cancer & clinical oncology.

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.

J. Forbes, P. Neven, C. Barrios, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial.

P. Neven, G. Jerusalem, O. Paija, 2012, Clinical breast cancer.

Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.

J. Neijt, J. Body, J. Elte, 1987, The American journal of medicine.

Palliative pamidronate treatment in patients with bone metastases from breast cancer.

J. Hermans, H. Kroon, G. Blijham, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation.

A. Cats, M. Jager, O. Bijvoet, 1982, Immunology.

COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIA

H. Sleeboom, O. Bijvoet, A. V. Oosterom, 1983, The Lancet.

Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries

J. Body, E. Terpos, N. Maniadakis, 2016, Journal of bone oncology.

Health resource utilization associated with skeletal-related events: results from a retrospective European study

H. Nahi, J. Body, E. Terpos, 2015, The European Journal of Health Economics.

Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study

J. Body, E. Terpos, N. Maniadakis, 2018, Journal of bone oncology.

Cost of skeletal complications from bone metastases in six European countries

J. Body, E. Terpos, N. Maniadakis, 2016, Journal of medical economics.

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.

H. Codrington, H. Sleeboom, L. W. Wormhoudt, 2008, European journal of cancer.

Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium

H. Mulder, H. Sleeboom, O. Bijvoet, 1982, Calcified Tissue International.

Minimising population health loss in times of scarce surgical capacity: a modelling study for surgical procedures performed in nonacademic hospitals

Eline M. Krijkamp, Josien Terwisscha van Scheltinga, G. V. van Ramshorst, 2022, BMC Health Services Research.

Fungal disease of the Western hemisphere: a patient with coccidioidomycosis.

G. Buijze, H. Sleeboom, Sierd J. Smith, 2009, European journal of internal medicine.

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.

C. Boni, H. Mouridsen, A. Monnier, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.

G. Scagliotti, F. Goldwasser, P. Woll, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.

C. Boni, H. Mouridsen, F. Jänicke, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.

J. Forbes, P. Neven, C. Barrios, 2013 .

Reply to S.M. Sorscher et al

G. Scagliotti, F. Goldwasser, V. Hirsh, 2011 .

Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?

J. Hermans, G. Blijham, S. Papapoulos, 1996, European journal of cancer.

Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer

E. Smets, A. Stiggelbout, C. Punt, 2017, Medical decision making : an international journal of the Society for Medical Decision Making.

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.

H. Codrington, H. Sleeboom, L. W. Wormhoudt, 2008, European journal of cancer.

Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times

A. V. van Oosterom, U. Tjaden, E. D. de Bruijn, 1992, International journal of cancer.